FDA Investigator Susan D Yuscius

Susan D Yuscius has inspections in 35 countries as of 14 Aug 2023. Susan D Yuscius has collaborated with a combinined 4575 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
320
Last Inspection Date:
14 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Romania, United States of America, Malta, Mexico, Poland, Colombia, United Kingdom of Great Britain and Northern Ireland, India, Switzerland, Argentina, Canada, Netherlands, China, France, Czechia, Belgium, Germany, Brazil, South Africa, New Zealand, Croatia, Latvia, Slovakia, Israel, Ireland, Japan, Dominican Republic, Italy, Spain, Sweden, Lithuania, Denmark, Austria, Serbia
Co-Investigator(s):
A Williams, Adam J Taylor, Alan M Barker, Alicia M Mozzachio, Allen F Hall, Amy M Cramer, Amy W Yan Mai, Ana E Morales, Anastasia M Shields, Andrace Lde Yampert, Andrew A Hoopes, Andrew A Leboeuf, Angela Shepas, Annette Melendez, Anthony E Keller, RPh, Ashley L Reiber, Atul J Agrawal, Audrey Dela Cruz, Azza Talaat, Barbara A Rusin, Barbara M Frazier, Bei Y He, Bradley J Maunder, Brandy D Brown, Brentley S Collins, Brian D Nicholson, Brian P Emanuel, Brian P Putz, Bruce H Mccullough, Bryan L Mcguckin, Carl A Huffman, III, Carmen Y Fisher, Carrie Ann Plucinski, Charles M Edwards, Charlie P Booker, Chery Grandinetti, Christina A Miller, Christopher D Leach, Colleen E Burke, Constantin Y Philopoulos, Cooperj, Courtney R Bratina, Craig A Garmendia, Cynthia A Harris, MD, RN, Cynthia A Palmer, Cynthia Jim, CSO, Cynthia L Rakestraw, Daniel L Aisen, Dariusz Galezowski, David J Gasparovich, David Perkins, Debra I Love, Debra L Boyd Seale, Denise M Digiulio, Dipesh K Shah, Don H Bark, PhD, Donna K Speer, Doretha M Tonkins, Dr. Barbara D Paul, PhD, Dr. Gopa Biswas, PhD, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Eboni S Funderburk, Edwardstine J Reese, Elizabeth L Holmes, Elizabeth L Philpy, Ellen P Madigan, Eric M Mueller, PharmD, Eric S Pittman, Erin M Mcdowell, Esther A Ofori, Farhana Khan, Felix J Marrero, Felix Maldonado, Francis A Guidry, Fulton A Varner, Gajendiran Mahadevan, PhD, Gene R Gunn, Geoffrey K Kilili, George C Amedro, Gregson A Joseph, Harperd, Hasan A Irier, PhD, Hugh M Mcclure, II, Jacob G Luts, Jacob G Lutz, James L Finn, James M Kewley, James P Duggan, James W Plucinski, Janae D Price, Javier O Vega, Jeanne J Chiu, Jeanne J Thai, Jennifer C Adams, Jennifer C Johnson, Jennifer L Sheehan, Jesse A Vazquez, Jessica L Pressley, Jill J Tillman, John A Iwen, John A Kadavil, PhD, John M Seale, Jose E Melendez, DDC, Joseph A Morkunas, Joseph A Piechocki, Joseph J Vannelli, Joseph L Despins, PhD, Joseph R Lambert, Joseph R Strelnik, Joshua M Adams, Joy P Matthias, Justin R Hays, Kara A Scheibner, PhD, Karen C Daugherty, Karen Emasley Joseph, Karen L Kosar, Karen M Cooper, Karen M Kondas, Kassa Ayalew, MD, Kathleen B Swat, Kathleen S Tormey, Kent A Conforti, Kham Phommachanh, Kinh Q Mac, Kip J Hanks, Kshitij A Patkar, Kujtim Sadiku, Lakecha N Lewis, Larry F Hallberg, Larry K Austin, Lata C Mathew, PhD, Laura E Garcia, Lauren A Crivellone, Lauren N Howard, Laurie A Haxel, Laurie B Frazier, Lawrence Y Lee, PhD, Leeterry Moore, Lequita M Mayhew, Li Hongpaul Yeh, PhD, Liliya V Bubiy, Linda E Whitehead, Linda S Leja, Lisa Hayka, Lisa Hornback, Lisa L Flores, Lisa P Oakes, Logan T Williams, Lynda L Lanning, M Patriciaurphy Murphy, Marc A Jackson, Jr, Marcellinus D Dordunoo, Marcia A Worley, Margaret Torres Vazquez, Maria A Reed, Mark G Peterson, Mark I Kaspar, Martin K Yau, PhD, Mathew T Thomas, MD, Matthew R Mcnew, Melkamu Getie Kebtie, PhD, Michael P Sheehan, Michael R Giammanco, Michael R Goga, Michele L Glendenning, Michele Perry Williams, Michelle J Glembin, Michelle M Noe, Mohsen Rajabi Abhari, FDA, Mpris Inspector, Mra Greenc, Nancy A Bellamy, Nantie, Nicholas C Mendiola, Nicholas P Diorio, Nicholas Z Lu, Nicola M Fenty Stewart, Nicole C Victoria, PhD, Nicole J Clausen, Nicole S Williams, Norman K Starks, Pablo Alcantara, Pal S Mayasandra, Paola S Barnett, Parul M Patel, Patricia A Mcilroy, Patrick C Klotzbuecher, Patrick E Gainer, Paul M Kawamoto, Paul W Moy, Paula M Laplant, Penny H Mccarver, Peter E Baker, Peterson, Phal K Chhun, Phung Thien Nguyen, Pradip N Akolkar, Rafael E Arroyo, Rafael Padilla, Ralph A Erickson, Randy D Baxter, Raymond T Oji, Rebecca Rodriguez, Regina T Brown, Richard W Berning, Robert C Steyert, Robert D Tollefsen, Robert J Ham, Roberta W Cunningham, Roger J Adams, Rosa J Motta, Ross J Grigsby, Russell K Riley, Samantha J Pinizzotto, D V M, Samina S Khan, Sandra A Hughes, Sandra L Shire, DMD, MPA, Sandra S Saniga, Seongeun Cho (Julia), PhD, Shafiq S Ahadi, Shalonda C Clifford, Sherbet L Samuels, Sherea L Dillon, Sherri J Jackson, Sonya L Karsik, Sripal R Mada, PhD, Stacey S Degarmo, State Agency, Stuart W Russell, Sullan, Susan E Molchan, MD, Susan P Bruederle, Susan Yuscius, Susanne M Richardson, MSc RAC ELS, Tara A Marshall, Tara C Alcazar, Tara K Carmody, Tawny L Colling, Tenzin Jangchup, That Q Dang, Thea C Grome, Thomas J Arista, Thomas W Nojek, Tiara Nbrown Crosen, Tong Zhou, Uruaku A Obasi, Veronica Fuentes, MS, Vioela J Caze, Walden H Lee, Wayne W Grundstrom, Xikui Chen (nmi), PhD, Yangmin Ning, Yiyue Zhang (nmi), PhD, Yuanyuan Li, Yvonne E Lozano

Susan D Yuscius's Documents

Publish Date Document Type Title
November, 2009 FDA 483 Berger, Daniel M.D. - Form 483, 2009-11-24
August, 2016 EIR Experimur, A Frontage Company - EIR, 2016-08-26
November, 2003 EIR AmericanAnalytical Chemistry Laboratories Corp. - EIR, 2003-11-24
December, 2001 FDA 483 Rising Pharma Holdings, Inc. - Form 483, 2001-12-17
December, 2000 EIR Reddy, Duttula M.D. - EIR, 2000-12-19
October, 2002 FDA 483 Response AmericanAnalytical Chemistry Laboratories Corp. - Form 483R, 2002-11-20
September, 2000 EIR Rising Pharma Holdings, Inc. - EIR, 2000-09-15
December, 2007 FDA 483 Aerosols Danville, Inc. dba Voyant Beauty - Form 483, 2007-12-07
January, 2008 FDA 483 AmericanAnalytical Chemistry Laboratories Corp. - Form 483, 2008-01-18
December, 2008 FDA 483 Barry Clemson, M.D. - Form 483, 2008-12-18
November, 2009 EIR Berger, Daniel M.D. - EIR, 2009-11-24
October, 2002 EIR AmericanAnalytical Chemistry Laboratories Corp. - EIR, 2002-10-25
May, 2000 FDA 483 Health Advance Institute - Form 483, 2000-05-03
February, 2009 EIR Abbott Molecular, Inc. - EIR, 2009-02-13
May, 2000 EIR Health Advance Institute - EIR, 2000-05-03
November, 2018 EIR AbbVie Inc. - EIR, 2018-11-16
May, 2011 FDA 483 MERICON INDUSTRIES, INC. - Form 483, 2011-05-27
March, 2001 FDA 483 Lincare Inc. - Form 483, 2001-03-28
April, 2001 EIR Paul, Allan, Dr. - EIR, 2001-04-06
August, 2010 EIR Hamilton Health Science Population Health Research Institute - EIR, 2010-08-20
August, 2018 EIR Amita Health IRB - EIR, 2018-08-23
February, 2000 EIR Rising Pharma Holdings, Inc. - EIR, 2000-02-08
April, 2018 FDA 483 Uptown Research Institute - Form 483, 2018-04-13
June, 2000 EIR Dr. E. Leen - EIR, 2000-06-16
November, 2010 EIR Decatur Memorial Hospital Irb - EIR, 2010-11-17
January, 2010 FDA 483 Rowland, Kendrith, MD - Form 483, 2010-01-20
June, 2000 EIR Professor Thomas Vogl, M.D. - EIR, 2000-06-22
April, 2018 FDA 483 Response Uptown Research Institute - Form 483R, 2018-04-19
June, 2000 FDA 483 Response Professor Thomas Vogl, M.D. - Form 483R, 2000-10-24
September, 2003 FDA 483 Meda Pharmaceuticals Inc. - Form 483, 2003-09-19
September, 2013 FDA 483 Alasdair Coles, Ph.D FRCP - Form 483, 2013-09-13
September, 2000 FDA 483 Rising Pharma Holdings, Inc. - Form 483, 2000-09-15
March, 2001 EIR Graham, Donald R., M.D. - EIR, 2001-03-07
August, 2007 FDA 483 Rising Pharma Holdings, Inc. - Form 483, 2007-08-17
February, 2011 EIR Barry Clemson, M.D. - EIR, 2011-02-04
February, 2001 EIR Nayak, Anjuli Seth, M.D. - EIR, 2001-02-23
October, 2002 FDA 483 AmericanAnalytical Chemistry Laboratories Corp. - Form 483, 2002-10-25
December, 2008 FDA 483 Response Barry Clemson, M.D. - Form 483R, 2009-05-21
January, 2010 EIR Rowland, Kendrith, MD - EIR, 2010-01-20
November, 2003 FDA 483 Response AmericanAnalytical Chemistry Laboratories Corp. - Form 483R, 2003-11-24
September, 2003 EIR Meda Pharmaceuticals Inc. - EIR, 2003-09-19
November, 2009 FDA 483 Response Berger, Daniel M.D. - Form 483R, 2010-01-11
November, 2003 FDA 483 AmericanAnalytical Chemistry Laboratories Corp. - Form 483, 2003-11-24
September, 2005 EIR Rising Pharma Holdings, Inc. - EIR, 2005-09-08
July, 2009 EIR Charles River Laboratories Montreal ULC - EIR, 2009-07-31
April, 2018 EIR Uptown Research Institute - EIR, 2018-04-13
July, 2008 EIR Takeda Global Research & Development - EIR, 2008-07-14
December, 2008 EIR Barry Clemson, M.D. - EIR, 2008-12-18
June, 2000 FDA 483 Response Dr. E. Leen - Form 483R, 2000-10-25
May, 2014 FDA 483 Professor Noel Gerard McElvaney - Form 483, 2014-05-02
May, 2000 EIR Rising Pharma Holdings, Inc. - EIR, 2000-05-16
January, 2010 FDA 483 Response Rowland, Kendrith, MD - Form 483R, 2010-02-03
September, 2006 FDA 483 Rising Pharma Holdings, Inc. - Form 483, 2006-09-29
August, 2012 EIR Wolfgang Loidl - EIR, 2012-08-09
November, 2010 FDA 483 Decatur Memorial Hospital Irb - Form 483, 2010-11-17
October, 2019 FDA 483 Frederick J. Snoy, M.D. - Form 483, 2019-10-11
December, 2000 FDA 483 Reddy, Duttula M.D. - Form 483, 2000-12-19

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more